仟源医药(300254.SZ)：以7736万元的价格竞得仟源海力生20%股权

Core Viewpoint - QianYuan Pharmaceutical (300254.SZ) is participating in a public auction to acquire a 20% stake in QianYuan HaiLiSheng, which is expected to enhance the company's operational performance and profitability [1] Group 1: Auction Details - The public auction for 40% of QianYuan HaiLiSheng is scheduled from February 24, 2026, to February 25, 2026, with an assessed value of 177.303197 million yuan and a starting price of 124.12 million yuan [1] - The deposit required for participation in the auction is 20 million yuan, with a minimum bidding increment of 600,000 yuan [1] Group 2: Acquisition Outcome - On February 25, 2026, the company, in collaboration with Zhoushan Ronghao, successfully acquired a 20% stake in QianYuan HaiLiSheng for 154.72 million yuan, with the company itself contributing 77.36 million yuan [1] - This acquisition is expected to provide continuous and stable investment returns and net profit contributions to the company [1] Group 3: Strategic Implications - The acquisition of the stake in QianYuan HaiLiSheng is anticipated to enhance the company's overall operational performance and profitability, thereby strengthening its sustainable development capabilities and competitive edge [1]